Carfilzomib-Induced Pneumotoxicity in a Lung Transplant Recipient
نویسندگان
چکیده
منابع مشابه
Atypical mycobacteriosis in a lung transplant recipient.
Although mycobacterial infections are more frequent in lung transplant recipients than in other solid organ recipients only occasional reports of infection from atypical Mycobacteria have been reported in patients receiving lung transplantation. We present a case of pleural and cutaneous infection due to Mycobacterium fortuitum in a double-lung transplant recipient. The infection was rapidly re...
متن کاملDyspnea in a lung transplant recipient.
Lung transplantation is the last resort for treatment of advanced lung disease or irreversible lung failure. The different types of acquired or genetic lung diseases that should be considered for lung transplantation include chronic obstructive pulmonary disease, emphysema, alpha-1 antitrypsin deficiency, cystic fibrosis and other causes of bronchiectasis, idiopathic pulmonary fibrosis, non-spe...
متن کاملUnusual manifestation of cutaneous Leishmaniasis in a renal transplant recipient
Cutaneous leishmaniasis may present as unusual manifestations in renal transplant patients receiving immunosuppressive therapy. This misleading presentation, may delay the diagnosis and treatment. Moreover special caution must be taken in renal transplant recipients because of possible interactions between antimony compounds and cyclosporine metabolites. We report a 45-year old man with 5 years...
متن کاملCommon infections in the lung transplant recipient.
Infections are a major cause of morbidity and mortality after lung transplantation. Pretransplant assessments for infection risk and immunization updates may help reduce posttransplant infections. In addition careful choice of posttransplant prophylaxis for cytomegalovirus and fungal infections is critical. Because of the potential association of infections such as respiratory viral infections ...
متن کاملLung Transplant Recipient with Pulmonary Alveolar Proteinosis
Pulmonary alveolar proteinosis (PAP) is a progressive lung disease characterized by accumulated surfactant-like lipoproteinaceous material in the alveoli and distal bronchioles. This accumulation is the result of impaired clearance by alveolar macrophages. PAP has been described in 11 solid organ transplant recipients, 9 of whom were treated with mammalian target of rapamycin inhibitors. We rep...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Heart and Lung Transplantation
سال: 2021
ISSN: 1053-2498
DOI: 10.1016/j.healun.2021.01.2052